Jin Kyung Rho Selected Research

Jin Kyung Rho Research Topics

Disease

42	Lung Neoplasms (Lung Cancer) 03/2024 - 10/2009
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 02/2007
27	Neoplasms (Cancer) 03/2024 - 07/2010
6	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2016
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2023 - 09/2013
4	Adenocarcinoma of Lung 12/2021 - 09/2013
3	Carcinogenesis 12/2022 - 12/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 08/2019
2	Hypoxia (Hypoxemia) 08/2009 - 03/2009
1	Hepatocellular Carcinoma (Hepatoma) 12/2023
1	Lung Diseases (Lung Disease) 09/2023
1	Adenocarcinoma 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2019
1	Lymphoma (Lymphomas) 10/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2019
1	Circulating Neoplastic Cells 08/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Pain (Aches) 11/2016
1	Pneumonia (Pneumonitis) 07/2015
1	Hemorrhage 07/2015
1	Fibrosis (Cirrhosis) 07/2015
1	Inflammation (Inflammations) 07/2015
1	Lung Injury 07/2015
1	Disease Progression 01/2014

Drug/Important Bio-Agent (IBA)

25	Tyrosine Kinase InhibitorsIBA 03/2024 - 10/2009
23	ErbB Receptors (EGF Receptor)IBA 03/2024 - 02/2007
13	Gefitinib (Iressa)FDA Link 11/2022 - 02/2007
8	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2019 - 12/2010
6	osimertinibIBA 03/2024 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2019
6	Phosphotransferases (Kinase)IBA 01/2019 - 07/2012
5	MicroRNAs (MicroRNA)IBA 09/2023 - 12/2011
4	Proteins (Proteins, Gene)FDA Link 08/2014 - 03/2009
3	silmitasertibIBA 01/2017 - 01/2014
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2020
2	Proto-Oncogene Proteins c-metIBA 11/2022 - 12/2011
2	PlatinumIBA 10/2022 - 01/2011
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2020 - 10/2019
2	Insulin-Like Growth Factor Binding Protein 3IBA 01/2019 - 01/2013
2	tyrosine receptor (receptor, tyrosine)IBA 01/2019 - 04/2017
2	Anaplastic Lymphoma KinaseIBA 11/2017 - 07/2015
2	Small Interfering RNA (siRNA)IBA 01/2017 - 03/2009
2	Casein Kinase II (Casein Kinase 2)IBA 01/2017 - 01/2014
2	Gallic AcidIBA 10/2016 - 08/2016
2	geldanamycinIBA 07/2015 - 01/2015
2	Silybin (Lagosa)IBA 07/2015 - 12/2010
2	Oncogene Proteins (Oncogene Protein)IBA 01/2015 - 09/2013
1	Cetuximab (Erbitux)FDA Link 03/2024
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2023
1	SERPIN-B5 (maspin)IBA 12/2023
1	Axl Receptor Tyrosine KinaseIBA 11/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	pembrolizumabIBA 10/2022
1	B7-H1 AntigenIBA 10/2022
1	purineIBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	pyrimidineIBA 01/2022
1	NucleotidesIBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	BIX 01294IBA 12/2021
1	Histone MethyltransferasesIBA 12/2021
1	RNA Polymerase II (RNA Polymerase B)IBA 09/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 10/2020
1	human MIRN619 microRNAIBA 10/2020
1	AfatinibIBA 06/2019
1	Vorinostat FDA Link 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	MatrinesIBA 01/2018
1	7-benzylidenenaltrexoneIBA 09/2017
1	Inhibitor of Apoptosis ProteinsIBA 09/2017
1	X-Linked Inhibitor of Apoptosis ProteinIBA 09/2017
1	maleic acid (maleate)IBA 09/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2017
1	Cell-Free Nucleic AcidsIBA 08/2017
1	3-methyladenineIBA 01/2017
1	AcidsIBA 08/2016
1	Pemetrexed (MTA)FDA Link 01/2016
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 07/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2015
1	EnzymesIBA 05/2015
1	Antineoplastic Agents (Antineoplastics)IBA 05/2015
1	AntioxidantsIBA 05/2015
1	PeroxiredoxinsIBA 05/2015
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2015
1	NPS-1034IBA 01/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014

Therapy/Procedure

10	Therapeutics 11/2023 - 07/2012
4	Radiotherapy 12/2023 - 07/2015
3	Drug Therapy (Chemotherapy) 03/2024 - 01/2011
2	Immunotherapy 11/2020 - 01/2020
1	Aftercare (After-Treatment) 03/2024
1	Precision Medicine 01/2021
1	Molecular Targeted Therapy 08/2019
1	Retreatment 04/2017